What is Magdent?
Magdent MED operates at the intersection of biotechnology and dental surgery, specializing in Pulsed Electromagnetic Field (PEMF) technology. By integrating magnetic healing solutions directly into dental implants, the company addresses critical clinical challenges such as peri-implantitis and suboptimal bone density. Their innovative platform is designed to accelerate post-surgical recovery times and enhance the structural integrity of implants, providing dental practitioners with a non-surgical tool to improve patient outcomes. As a leader in regenerative dental solutions, Magdent is effectively redefining the standard of care for complex implant procedures, moving beyond traditional mechanical stability toward biologically active healing environments.
How much funding has Magdent raised?
Magdent has raised a total of $1.8M across 1 funding round:
Angel/Seed
$1.8M
Angel/Seed (2017): $1.8M, investors not publicly disclosed
Key Investors in Magdent
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Magdent?
With this major enterprise-level funding, Magdent is poised to accelerate its research and development pipeline and expand its commercial footprint within the global dental market. The strategic allocation of capital will likely focus on clinical validation studies and the scaling of manufacturing capabilities to meet the growing demand for advanced implantology solutions. By leveraging its PEMF technology, the company aims to solidify its market position as a primary provider of regenerative dental hardware. Future growth will likely involve deepening partnerships with dental clinics and academic institutions to further integrate their magnetic healing solutions into standard surgical protocols, ultimately driving higher success rates for dental implants worldwide.
See full Magdent company page
